STAGE III ENDOMETRIAL CANCER
Clinical trials for STAGE III ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for STAGE III ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer trial cuts radiation time from 5 weeks to just 1
Disease control Recruiting nowThis study is testing whether a much shorter, one-week course of targeted pelvic radiation, given alongside standard chemotherapy drugs, is practical for patients to complete. It aims to see if this combined approach is manageable for people with stage III endometrial cancer who …
Matched conditions: STAGE III ENDOMETRIAL CANCER
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists hunt genetic clues to predict uterine Cancer's return
Knowledge-focused Recruiting nowThis study aims to understand why high-risk endometrial cancer comes back after treatment. Researchers will collect blood and tissue samples from 100 patients to analyze their cancer's genetic makeup. The goal is to identify genetic patterns that might help predict recurrence and…
Matched conditions: STAGE III ENDOMETRIAL CANCER
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:25 UTC